Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Vaccinations

Vaccinations

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Genital Herpes

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

US Preventive Services Task Force: What Does the Future Hold?

American family physician·2026

Same author

Advisory Committee on Immunization Practices Standards for Assessing Evidence.

JAMA·2025

Same author

Practice Alert: Meningococcal Vaccines.

American family physician·2025

Same author

Practice Alert: Pneumococcal Conjugate Vaccines Approved for Adults.

American family physician·2025

Same author

Practice Alert: CDC Guidelines on Doxycycline for STI Postexposure Prophylaxis.

American family physician·2024

Same author

Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.

MMWR. Morbidity and mortality weekly report·2024

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

The case for HPV immunization.

Doug Campos-Outcalt¹

¹Department of Family and Community Medicine, University of Arizona College of Medicine, Phoenix, AZ, USA. dougco@u.arizona.edu

The Journal of Family Practice

|December 8, 2009

Summary

Human papillomavirus (HPV) vaccines are now available for boys. A second vaccine for HPV-associated cancer prevention is approved, prompting discussion on clinical use.

Area of Science:

Oncology
Immunology
Public Health

Background:

Human papillomavirus (HPV) infections are a leading cause of several cancers.
Vaccination is a primary strategy for cancer prevention.
Recent advancements include expanded vaccine availability and new formulations.

Purpose of the Study:

To review the current landscape of HPV vaccines.
To discuss the implications of new vaccine approvals and availability for boys.
To guide clinicians on the integration of these vaccines into practice.

Main Methods:

Literature review of HPV vaccine efficacy and safety studies.
Analysis of current HPV vaccination guidelines.
Synthesis of data on HPV-associated cancer incidence and prevention.

More Related Videos

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Related Experiment Videos

Last Updated: Jun 18, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Main Results:

The quadrivalent HPV vaccine (HPV4) is now indicated for boys.
A second vaccine targeting additional HPV types has received approval.
Evidence supports the efficacy of HPV vaccination in preventing HPV-associated cancers in both males and females.

Conclusions:

The expanded availability of HPV vaccines for boys represents a significant public health advancement.
Clinicians should consider incorporating the updated HPV vaccination recommendations into their practices.
Widespread vaccination is crucial for reducing the burden of HPV-associated cancers.